Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
Dennis C. Copertino, Rodrigo R. R. Duarte, Timothy R. Powell, Miguel de Mulder Rougvie, Douglas F. Nixon
Topics & Concepts
MontelukastCytokine stormImmunologyMedicineCoronavirusImmune systemVirologyAntiviral drugProinflammatory cytokinePharmacologyVirusInflammationCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)Internal medicineAsthmainterferon and immune responsesCOVID-19 Clinical Research StudiesSynthesis and biological activity